Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Karyopherin subunit beta 1 pseudogene 1 (KPNB1P1) is a non-coding, nonfunctional DNA sequence present in the human genome that closely resembles the functional KPNB1 gene, which encodes importin subunit beta-1, a key nuclear transporter[4][5]. Unlike KPNB1, KPNB1P1 lacks the ability to produce a functional protein due to disabling mutations typical of pseudogenes, such as premature stop codons or frameshift indels[5]. Most pseudogenes, including KPNB1P1, do not participate in known biological processes, serve as therapeutic targets, or influence disease pathways. While a few pseudogenes can exert regulatory effects at the transcript level in some circumstances, no such function has been established for KPNB1P1. Therefore, it is not considered a therapeutic, diagnostic, or functional biomolecular target[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Karyopherin subunit beta 1 pseudogene 1 (KPNB1P1).